WWHS Biotech.Inc(exclusive marketed by Dawin)
| Payment Terms | T/T |
| Supply Ability | 30000 Kits per Week |
| Delivery Time | 7 Days |
| Packaging Details | Colorful Paper Box |
| Product Name | PG I Rapid Quantitative Test Kit |
| Type | One Step Assay |
| Reactivity | Human |
| Formal Name | Thyroxine |
| Manufacturer | WWHS Biotech INC |
| Advantage | High Sensitivity |
| Throughput | 3000 Tests/Day |
| Format | Cassette |
| Usage | Tumor Marker |
| Keywords | High Stability, High Accuracy |
| Brand Name | WWHS |
| Model Number | PGI |
| Certification | CE |
| Place of Origin | CN |
View Detail Information
Explore similar products
WWHS SARS-CoV-2 Antigen FIA Rapid Quantitative Test Kit POCT Assay
Ca125 Rapid Quantitative Test Kit Fluorescence Immunoassay Tumor Maker
FIA Quantitative PSA Rapid Test Kit Dry Fluoroimmunoassay Analyser
CYFRA21-1 Colloidal Gold POCT FIA Rapid Test Kit CE Approved IVD Assay
Product Specification
| Payment Terms | T/T | Supply Ability | 30000 Kits per Week |
| Delivery Time | 7 Days | Packaging Details | Colorful Paper Box |
| Product Name | PG I Rapid Quantitative Test Kit | Type | One Step Assay |
| Reactivity | Human | Formal Name | Thyroxine |
| Manufacturer | WWHS Biotech INC | Advantage | High Sensitivity |
| Throughput | 3000 Tests/Day | Format | Cassette |
| Usage | Tumor Marker | Keywords | High Stability, High Accuracy |
| Brand Name | WWHS | Model Number | PGI |
| Certification | CE | Place of Origin | CN |
PG I Rapid Quantitative Test Kit IFA Colloidal Gold CE Approval IVD Blood Diagnostic
Phosphoglucose isomerase (glucose-6-phosphate isomerase or PGI, EC 5.3.1.9) is an important housekeeping enzyme. PGI catalyzes the interconversion of glucose-6- phosphate to fructose-6-phosphate. PGI performs multiple functions & intracellularly plays key role in both glycolysis and gluconeogenesis. Extracellularly, PGI [also called Autocrine Motility Factor (AMF)] functions as a cytokine, which stimulates cell motility and is associated with tumor development and metastasis. In humans, PGI deficiency causes hemolytic anemia, whereas increased PGI activity is observed in many cancers such as gastrointestinal, kidney and breast cancer. Early detection of abnormal phosphoglucose isomerase activity is crucial for diagnosis, prediction and therapeutic strategy.
About NIR-1000 Dry Fluoroimmunoassay Analyser
It is a fluorescence immunochromatographic analysing system with internal temperature control,
which can help diagnose conditions such as infection, diabetes, cardiovascular diseases, renal injury and cancers, etc.
Immunofluorescence technology
Testing time less than 15 minutes
Easy-to-use touch-screen platform,multi-language system
Note:
1) Any variation in operator, pipetting and washing technique, incubation time or temperature, and kit age can cause variation in
result. Each user should obtain their own standard curve.
2) If samples have been diluted, the concentration read from the standard curve must be multiplied by the dilution factor.
3) If specimens generate values higher than the highest standard, dilute the specimens and repeat the assay
| Assay list | Tumor Marker | |||||
| cat#. | Product item | Specimen | Reaction Time | Measure Range | Clinical Range | Itended Use |
| 20 | AFP | Serum/Plasma | 15min. | 2.5-200ng/ml | <20ng/ml | pregnancy cancer |
| 21 | CEA | Serum/Plasma | 15min. | 1-200ng/ml | <5ng/ml | colon cancer, colorectal cancer,etc. |
| 22 | NSE | Serum/Plasma | 15min. | 1-400ng/ml | <16ng/ml | non-small cell lung cancer |
| 23 | FOB | fecal specimens | 10min. | 50-1000ng/ml | <100ng/ml | Abnormal recessive gastrointestinal bleeding |
| 24 | PG II | Serum/Plasma | 15min. | 1-100ug/L | PGI/PGII>3.0 | gastric abnormalities |
| 25 | PG I | Serum/Plasma | 15min. | 2.5-200ug/L | >70ng/ml | gastric abnormalities |
| 26 | TPSA | Serum/Plasma | 15min. | 0.5-40ng/ml | <4ng/ml | prostate cancer |
| 27 | FPSA | Serum/Plasma | 15min. | 0.1-10ng/ml | <1ng/ml | prostate cancer |
| 28 | CA12-5 | Serum/Plasma | 15min. | 20-500U/ml | <35U/ml | ovarian cancer |
| 29 | CA15-3 | Serum/Plasma | 15min. | 10-400U/ml | < 25 U/mL | breast cancer |
| 30 | HE4 | Serum/Plasma | 15min. | 50-2000pmol/L | <140 pmol/L | ovarian cancer |
| 31 | CA19-9 | Serum/Plasma | 15min. | 10-400U/ml | < 27 U/mL | pancreatic cancer |
| 32 | β-HCG | Serum/Plasma | 15min. | 5-400mIU/ml | <10 mIU/mL | Early pregrancy, ectopic HCG cancer,incomplete abortion |
| 33 | CK19(Cyfra21-1) | Serum/Plasma | 15min. | 0.5-50ng/ml | <2.5ng/ml | non-small cell lung cancer |
Company Details
Business Type:
Manufacturer,Exporter
Year Established:
2016
Total Annual:
3000-5000
Employee Number:
50~80
Ecer Certification：
Site Member
As A Fast-Growing Biotechnology Company, WWHS Biotech.Inc(exclusive marketed by Dawin) Dedicate To The Development Of World-Class Bio-Detection Technologies That Meet The Ever-Increasing Demands On Clinical Diagnostics. We Focus On Developing Cost-Effective And Precise Rapid Diagnostic Products... As A Fast-Growing Biotechnology Company, WWHS Biotech.Inc(exclusive marketed by Dawin) Dedicate To The Development Of World-Class Bio-Detection Technologies That Meet The Ever-Increasing Demands On Clinical Diagnostics. We Focus On Developing Cost-Effective And Precise Rapid Diagnostic Products...
Get in touch with us
Leave a Message, we will call you back quickly!